![]() |
|
|
-Induced Metallothionein-1 Expression in Rats
Manuscript received 1 July 1997. Initial reviews completed 8 August 1997. Revision accepted 16 March 1998.
Department of Pediatric Surgery, * First Department of Surgery, Osaka University Medical School, Osaka 565, Japan
This study investigated whether interleukin-1
-induced metallothionein gene expression is affected by zinc deficiency. Weaning male rats were fed a zinc-deficient (ZD) diet (2 mg zinc/kg) or a zinc-supplemented diet [50.8 mg zinc/kg; controls for the diet included pair-fed (PF) and ad libitum consumption groups (AL)] for 4 wk. All rats except those that served as controls for interleukin-1
administration, (injected with vehicle and killed at 0 h) were then injected subcutaneously with interleukin-1
(2 × 107 units/kg body wt) and killed at 3, 6, 12, 24 and 72 h after the injection. Compared with AL and/or PF rats, zinc depletion significantly reduced zinc concentrations in plasma and liver but not in kidney or intestine, and significantly reduced hepatic, renal, and intestinal metallothionein-1 mRNA levels analyzed by competitive reverse transcription-polymerase chain reaction (RT-PCR). Interleukin-1
injection reduced plasma zinc concentration and enhanced liver zinc concentration, but did not affect zinc levels in kidney or intestine. Metallothionein-1 mRNA was significantly elevated by interleukin-1
in liver, kidney and intestine of all groups; the levels in liver and kidney of ZD rats 6 h after the injection were significantly higher than those of AL or PF rats. Liver metallothionein protein levels were enhanced after interleukin-1
injection in both AL and ZD rats. Semiquantitative RT-PCR revealed significantly higher hepatic levels of interleukin-1 receptor type-I mRNA in ZD rats than in AL and PF rats but no differences in renal or intestinal tissues among groups before interleukin-1
challenge. In conclusion, zinc deficiency induces upregulation of metallothionein-1 gene expression in response to interleukin-1
challenge in rats.
The Journal of Nutrition Vol. 128 No. 7 July 1998,
pp. 1092-1098
Copyright ©1998 by the American Society for Nutritional Sciences
This article has been cited by other articles:
![]() |
J. C. Philcox, M. Sturkenboom, P. Coyle, and A. M. Rofe Metallothionein in Mice Reduces Intestinal Zinc Loss during Acute Endotoxin Inflammation, but Not during Starvation or Dietary Zinc Restriction J. Nutr., August 1, 2000; 130(8): 1901 - 1909. [Abstract] [Full Text] |
||||
![]() |
E. Mocchegiani and M. Muzzioli Therapeutic Application of Zinc in Human Immunodeficiency Virus against Opportunistic Infections J. Nutr., May 1, 2000; 130(5): 1424S - 1431. [Abstract] [Full Text] |
||||
![]() |
D. A. Suhy, K. D. Simon, D. I. H. Linzer, and T. V. O'Halloran Metallothionein Is Part of a Zinc-scavenging Mechanism for Cell Survival under Conditions of Extreme Zinc Deprivation J. Biol. Chem., April 2, 1999; 274(14): 9183 - 9192. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cui, Y. Takagi, M. Wasa, K. Sando, J. Khan, and A. Okada Nitric Oxide Synthase Inhibitor Attenuates Intestinal Damage Induced by Zinc Deficiency in Rats J. Nutr., April 1, 1999; 129(4): 792 - 798. [Abstract] [Full Text] |
||||